Headlines for [MDT]

• MDT 11/19/2008 08:21am
  Medtronic Inc Price target cut to $44 from $62 at Stifel, maintains buy rating
  
• MDT 11/19/2008 06:43am
  Medtronic Inc Price Target lowered to $50 from $60 at Merrill, maintains buy rating
  
• MDT 11/19/2008 00:17am
  Medtronic Inc The DoJ is probing the off-label use of the company's INFUSE bone growth product - WSJ- The regulators are investigating the use of INFUSE for the treatment of heart problems. - The safety concerns more...
  
• MDT 11/18/2008 08:34am
  Medtronic Inc Cuts FY09 EPS guidance to $2.90-2.98 v $2.99e ($2.94-3.02 prior), R $14.6-15B v $15.2Be- EPS cut due to first factor is a $0.03 per share charge associated with the write off of inventory made more...
  
• MDT 11/18/2008 08:12am
  Medtronic Inc CEO: Confident in double digit EPS growth in H209 - conf call- Says have received DoJ subpoena regarding spine product
  

Healthcare sector headlines

• NCST Today 09:48am
  Nucryst Pharmaceuticals Corp Majority holder calls for special meeting of shareholders to consider a return of capital of $0.80/shr
  
• GNBT Today 09:30am
  Generex Biotechnology Announces Positive Results of Metformin Chewing Gum Trial- Results of this fully compliant ICH-GCP conducted study indicate that the MetControl Metformin chewing gum and traditional Metformin tablets more...
  
• Today 09:30am
  Fed sets overnight reverse repos, accepts $25B
  
• 4568.JP Today 09:28am
  Daiichi Sankyo Co Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology- Results from three studies of its investigational molecule, DU-176b, will more...
  
• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...